How to Prevent Protein Aggregation

What You Need to Know

Protein aggregation can compromise therapeutic efficacy, safety, and regulatory approval. Preventing aggregation requires a combination of smart formulation design, rigorous analytical monitoring, and expert guidance. This guide covers some of the causes of protein aggregation, practical prevention strategies, and how BioPharmaSpec's analytical services can support your development pipeline.

What Is Protein Aggregation?

Protein aggregation refers to the unwanted clumping or association of protein molecules, often due to environmental stresses such as pH shifts, temperature changes, shear forces, or formulation incompatibilities.

For biopharmaceutical developers, aggregation poses critical challenges:

Loss of therapeutic efficacy
Increased immunogenicity risk
Regulatory non-compliance
Reduced product shelf life and stability

Understanding how to prevent protein aggregation early in development is vital for both product quality and patient safety.

What Causes Protein Aggregation?

Common triggers include:

High protein concentration during formulation
Thermal stress during processing or storage
pH shifts causing electrostatic instability
Mechanical agitation or shear during mixing, filtration, or pumping
Exposure to interfaces, such as air-liquid or vial surfaces
Freeze-thaw cycles that destabilise protein structure

Each protein behaves differently. Aggregation prevention must be tailored to the molecule's structure, folding pathway, and formulation environment.

Seven Strategies for Protein Aggregation Prevention

1. Optimise pH and Ionic Strength

2. Use Stabilising Excipients

Sugars (e.g. sucrose, trehalose) for thermal protection
Amino acids (e.g. Arginine) to minimise hydrophobic interactions
Surfactants (e.g. polysorbate 20/80) to reduce interface stress
Polyols (e.g. glycerol) to improve protein solubility

Stabilising excipients help preserve the native protein conformation under stress, reducing the chance of aggregation due to partial unfolding. These additives, collectively known as protein stabilizers, must be screened case-by-case. Some may introduce new degradation risks.

3. Control Temperature During Processing and Storage

4. Reduce Agitation and Shear Forces

5. Avoid Freeze-Thaw Cycles

6. Use Low-Binding Surfaces

7. Perform Stress Testing Early

How Can You Measure Aggregation Effectively?

A range of analytical techniques can be used to assess aggregate size, distribution, and composition at different stages of the development process. Below are some of the most widely used tools:

SEC-MALS (Size Exclusion Chromatography - Multi-Angle Light Scattering)
- This technique separates native protein from aggregated forms based on chromatographic separation, helping to quantify monomers, dimers, trimers, and larger aggregates in solution.
Dynamic Light Scattering (DLS)
- Measures hydrodynamic radius and polydispersity.
Analytical Ultracentrifugation (AUC)
- This technique separates native protein from aggregated forms based on sedimentation rates, helping to quantify monomers, dimers, trimers, and larger aggregates in solution.

BioPharmaSpec Offers:

Custom aggregation studies tailored to your biologic
ICH-aligned characterization methods
Comparability data for biosimilar development or process changes
Hands-on interpretation from scientists with decades of biopharma experience

Whether you're working on monoclonal antibodies, recombinant proteins, fusion proteins, or novel scaffolds, our analytical support helps you assess aggregation issues specific to your product.

Tackle Protein Aggregation with Confidence

Work directly with our PhD-level scientists to develop a custom analytical strategy tailored to your formulation and regulatory needs.

SPEAK TO A SCIENTIST

Conclusion

At BioPharmaSpec, we provide orthogonal analytical approaches to aggregation assessment, something highly valued by the EMA and FDA, helping you to understand and develop preventative strategies.

Want to ensure your biologic stays stable from lab to launch? Contact BioPharmaSpec for a comprehensive investigation of your sample’s aggregation profile.